From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Cardiology>
  4. Summary and Comment

Statins and Cognitive Impairment

Findings from a prospective observational study support the thesis that statin use may protect against the eventual development of dementia.

Research findings regarding the posited effects of statins on declining cognitive function are inconsistent. To explore statins’ associations with dementia and with cognitive impairment, no dementia (CIND), investigators analyzed data from a population-based cohort of participants 60 and older in the Sacramento Area Latino Study on Aging (SALSA).

A total of 1674 participants had no dementia or CIND at baseline. Of these, 452 (27%) used statins at baseline or during the 5-year follow-up period; 43 participants who used other, nonstatin lipid-lowering therapies were classified with the statin nonusers. Of the statin users, 58% took them for ≥2 study years. Although statin users and nonusers were comparable with respect to many baseline characteristics, a significantly higher percentage of statin users than nonusers had a history of diabetes. During follow-up, 130 participants developed dementia or CIND. In unadjusted analysis, statin use was associated with a 43% decrease in the rate of dementia or CIND, compared with statin nonuse. In a Cox proportional hazards-adjusted model, the rate of dementia or CIND was 44% lower among statin users than among nonusers.

Comment: In this predominantly Mexican American population, statin use was associated with a lower rate of dementia or cognitive impairment without dementia than statin nonuse. However, randomized trials of statins for primary prevention of any kind of dementia or cognitive decline in different populations are needed before statins are routinely deployed to prevent cognitive decline.

Joel M. Gore, MD

Published in Journal Watch Cardiology July 28, 2008

Citation(s):

Cramer C et al. Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study. Neurology 2008 Jul 29; 71:344.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Related Content

Other Perspectives

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2008. Massachusetts Medical Society. All rights reserved.